Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Begins

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cynapsus Therapeutics Inc. : Cynapsus Therapeutics Begins Trading on the OTCQX Marketplace in the United States

TORONTO--(Marketwired - Jul 18, 2013) -


July 18, 2013

Cynapsus Therapeutics Inc. (TSX-V: CTH) ( OTCQX : CYNAF ) ("Cynapsus" or the "Corporation") today announced that its common shares have been approved for trading in the United States on the OTCQX marketplace ("OTCQX"). Trading is expected to commence immediately on OTCQX International under the symbol CYNAF. The Corporation will continue to trade on the TSX Venture Exchange under its existing symbol CTH.

OTCQX International is a segment of the OTCQX marketplace reserved for high-quality non-U.S. companies that are listed on a qualified foreign stock exchange, undergo management reviews and provide their home country disclosure to U.S. investors. U.S. investors can find information and Real-Time Level 2 quotes for the Corporation on www.otcmarkets.com . Troutman Sanders LLP will act as the Corporation's Principal American Liaison ("PAL") on the OTCQX.

Anthony Giovinazzo, Cynapsus' President and Chief Executive Officer said, "We are very pleased to have achieved this strategic objective of providing U.S. investors with efficient access to our stock. We believe that all shareholders will benefit from the Corporation's exposure to a larger number of retail and institutional investors."

About Cynapsus Therapeutics

Cynapsus is a specialty pharmaceutical company developing the only oral (sublingual) delivery of the only approved drug (apomorphine) to be used as a rescue therapy for "off" motor symptoms of Parkinson's disease. Over one million people in the U.S. and an estimated 5 million people globally suffer from Parkinson's disease. Parkinson's disease is a chronic and progressive neurodegenerative disease that impacts motor activity, and its prevalence is increasing with the aging of the population. Based on a recent study and the results of the Company's Global 500 Neurologists Survey, it is estimated that between 25 percent and 50 percent of patients experience "off" episodes in which they have impaired movement or speaking capabilities. Current medications only control the disease's symptoms, and most drugs become less effective over time as the disease progresses.

Cynapsus' drug candidate, APL-130277, is an easy-to-administer, fast-acting reformulation of apomorphine, which is approved in an injection formulation to rescue patients from "off" episodes. Cynapsus is focused on maximizing the value of APL-130277 by completing pivotal studies in advance of a New Drug Application expected to be submitted in 2015. Cynapsus anticipates a trade sale or out-licensing to an appropriate global pharmaceutical partner before such an application is submitted.

More information about Cynapsus (TSX-V: CTH) ( OTCQX : CYNAF ) is available at www.cynapsus.ca and at the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com .

Forward Looking Statements

This announcement contains "forward-looking statements" within the meaning of applicable Canadian securities legislation. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Cynapsus to be materially different from those expressed or implied by such forward-looking statements, including but not limited to those risks and uncertainties relating to Cynapsus' business disclosed under the heading "Risk Factors" in its Annual Information Form filed on November 1, 2012 and its other filings with the various Canadian securities regulators which are available online at www.sedar.com . Although Cynapsus has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Cynapsus does not undertake to update any forward-looking statements, except in accordance with applicable securities laws.

--30--

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Cynapsus Therapeutics Inc. via Thomson Reuters ONE

[HUG#1717219]

Contacts Cynapsus Therapeutics: Anthony Giovinazzo President and CEO (416) 703-2449 x225 Email Contact Cynapsus Therapeutics Andrew Williams COO & CFO (416) 703-2449 x253 Email Contact www.cynapsus.ca

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 111

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 30

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 36

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 0

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 259

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 176

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 0

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 151

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 41

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 23

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripplecoin Mining Unveils Revolutionary Cloud Mining App

Updated Category News Views 160

Introducing the Latest in Cloud Mining Technology Ripplecoin Mining has launched a state-of-the-art mobile application designed to enhance the cloud mining experience for cryptocurrency enthusiasts. Since its inception in 2017, Ripplecoin Mining has positioned itself as a leader in the industry. This exciting update allows users to effortlessly manage their cryptocurrency...

Continue Reading
AMSURG Centers Shine in National Human Experience Awards 2025

Updated Category News Views 108

AMSURG Centers Celebrate National Recognition AMSURG, a distinguished leader in ambulatory surgery center services, is thrilled to announce that three of its esteemed centers have been honored in the latest round of the Human Experience Awards. These awards, conferred by a renowned leader in healthcare experience solutions, aim to recognize organizations across the...

Continue Reading
Wynn Resorts Gains Momentum with Upgraded Growth Outlook

Updated Category News Views 276

Wynn Resorts got a jolt back in 2024 when Morgan Stanley raised its rating from Equal-weight to Overweight, pushing the price target up from $97 to $104. Traders perked up at the mention of a 25% upside, which suggested to many that there was solid potential brewing for those willing to take the plunge. Factors Driving the Upgrade: Opportunity Awaits This upgrade wasn't...

Continue Reading
Innovative Toilet Cleaning Solution for a Fresher Home

Updated Category News Views 117

Introducing the Sani Flush – A Revolution in Toilet Cleaning In the quest for cleaner and more sanitary bathroom experiences, a new invention has emerged. The Sani Flush - Toilet Refresher is designed to transform the way we think about toilet hygiene. Developed by a passionate inventor, this product offers a unique solution for maintaining cleanliness in toilet bowls...

Continue Reading
Understanding the Legal Rights of Fly-E Group Stakeholders

Updated Category News Views 205

Overview of Fly-E Group, Inc. Fly-E Group, Inc. is committed to revolutionizing sustainable transportation through its innovative electric vehicles powered by cutting-edge lithium battery technology. Investors in the company should stay informed about potential legal matters that may affect their investments, especially in light of recent events. Class Action Securities...

Continue Reading